פריוויג'ן

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

IMMUNOGLOBULINS, NORMAL HUMAN

Mevcut itibaren:

CSL BEHRING LTD., ISRAEL

ATC kodu:

J06BA02

Farmasötik formu:

תמיסה לאינפוזיה

Kompozisyon:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Uygulama yolu:

תוך-ורידי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

CSL BEHRING AG, SWITZERLAND

Terapötik grubu:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Terapötik alanı:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Terapötik endikasyonlar:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Yetkilendirme tarihi:

2016-06-30